Genetic Analysis summarizes this year's product development activities and looks ahead to 2024
OSLO, NORWAY - December 13, 2023: Today, the Microbiome DX company Genetic Analysis AS ("GA" or the "Company") publishes a summary of the current year's product development and ongoing studies. The Company now looks ahead to the value-adding milestones in 2024.Ronny Hermansen, CEO of Genetic Analysis, comments: "A lot of important innovative progress has been demonstrated at GA in the past year, and I am pleased to give an update on all the product development results we have achieved during 2023. This development strengthens our position as a key player in the microbiome diagnostic